Our research infrastructure
Our long-term investment in state-of-the-art facilities has helped to create a thriving network of research across the UK.
在CRUK，我们认识到基础设施在创造动态和响应式研究环境中所发挥的关键作用。我们的基础设施为癌症研究的全部广度和转化管道提供了能力，从基本生物学研究到交付后期临床试验，并支持与大学和NHS的密切合作伙伴关系。
下面探讨我们的能力,或view our facilities by geographical location
Our Institutes
Our four core-funded research institutes provide an exceptional environment for discovery science, and have an outstanding track record including four Nobel Prize winners. More than a third of our research spend goes to our institutes, funding over 120 research groups across the breadth of cancer science, supported by state-of-the-art facilities.
Alongside the CRUK Beatson Institute in Glasgow, the CRUK Cambridge Institute and the CRUK Manchester Institute, we're partners in the multidisciplinary Francis Crick Institute in London – Europe’s largest single-location biomedical research institute.
Our Centres
Our network of 7 translational research centres drives local collaborations between universities, NHS hospitals, and other research organisations. Together, they operate as a network which plays a key role in delivering our strategic objectives in translational research, with different centres contributing their expertise in different tumour sites and research themes.
We award centre status to locations performing the highest quality cancer research, and we provide over £100million of infrastructure investment funding across the network for technical staff, equipment, training and running costs, developing the breadth and depth of research at each of these centres.
癌症研究Horizons
Our new innovation engine, Cancer Research Horizons, comprises over 200 scientists across 6 innovation hotspots, including our close academic partner, Newcastle University. We're united under a single leadership team with a singular focus:to fast-track scientific breakthroughs into patient benefit。在癌症研究视野中汇集的药物发现站点为研究人员和合作伙伴提供了对全部药物发现的访问权限，包括深层生物学，药理学和药物化学知识和专业知识所支撑的最新能力。
Our Centre for Drug Development
我们的药物开发中心（CDD）将当今的科学转化为明天的医学。CDD是由慈善资助的药物开发小组独特的，有100多名科学家和运营人员在临床前和早期发展过程中提供全部功能。
The CDD is a centre of excellence providing expertise and facilities to the academic research community and also partnering with industry to accelerate early phase drug development.
Our Open Lab Initiative
OurOpen Lab Initiativeencourages CRUK Centre Network research groups, CRUK-funded laboratories, and other groups undertaking cancer-related research, to hold joint group meetings online. Our aim is to connect research groups with similar interests and expertise from across the UK.
- The first step in meeting your future new collaborators is to simply express your interest in the Initiative by completing our表达兴趣形式。
- You will then receive a link giving you full access to the Initiative's SharePoint site.
- 一旦您可以访问该网站，您将被要求提供研究小组的兴趣和专业知识的详细信息，以及有关您从比赛中寻找的信息的一些信息。bet188体育在线投注然后，我们将使用此信息将您与另一个研究小组匹配，以举行联合虚拟小组会议。另外，您可以将研究组添加到我们的公开注册中，以允许其他人bet188体育在线投注直接与您匹配。
If you have any questions, queries or feedback, please email the Open Lab Initiative Team atopenlab@cancer.org.uk
Our network around the UK
We support a thriving UK-wide ecosystem with capabilities across the research and translational pipelines, from basic biological research to the delivery of late-phase clinical trials:
Institutes
Cambridge, Glasgow, Manchester, London: Francis Crick Institute
Centres
Cambridge, City of London (Kings College London, University College London, Barts Cancer Institute, Francis Crick Institute), Convergence Science Centre (Institute of Cancer Research-Imperial College London), Manchester, Newcastle, Oxford, Scotland (Edinburgh-Glasgow)
Brain Tumour Centre of Excellence
University College London-Edinburgh University
Children’s Brain Tumour Centre of Excellence
Institute of Cancer Research (London)-University of Cambridge
Experimental Cancer Medicine Centres (ECMCs)
Adult and paediatric:
Birmingham, Cambridge, Glasgow, Liverpool, London: Institute of Cancer Research, University College London, Manchester, Newcastle Upon Tyne, Southampton
Adult:
Belfast, Cardiff, Edinburgh, Leicester, London: Barts, London: Imperial, London: King’s College, Oxford, Sheffield
Paediatric:
布里斯托尔，利兹
癌症研究Horizons Drug Discovery Facilities
Cambridge, Glasgow, Francis Crick Institute, Newcastle
癌症研究视野 - 焦点抗体联盟实验室
Cambridge
癌症研究Horizons-AstraZeneca Functional Genomics Centre
Cambridge
Lung Cancer Centre of Excellence
University College London-University of Manchester
RadNet
Cambridge, Glasgow, Leeds, City of London Centre (KCL, UCL, Barts, the CRICK), London: Institute of Cancer Research, Manchester, Oxford
National Cancer Imaging Translational Accelerator (NCITA)
Cambridge, Glasgow, Institute of Cancer Research, London: Imperial College London, King’s College London, University College London, Manchester, Newcastle, Oxford
Clinical Trials Units
Birmingham, Cardiff, Glasgow, Leeds, London: Institute of Cancer Research, London: King’s College, London: University College London, Southampton
International Alliance for Cancer Early Detection (ACED)
Cambridge, University College London, Manchester
Manufacturing Facility
格拉斯哥（配方单元）
